Robeco Institutional Asset Management B.V. Purchases 58,567 Shares of Procter & Gamble Company (The) $PG

Robeco Institutional Asset Management B.V. raised its position in Procter & Gamble Company (The) (NYSE:PG) by 6.6% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 945,355 shares of the company’s stock after purchasing an additional 58,567 shares during the quarter. Robeco Institutional Asset Management B.V.’s holdings in Procter & Gamble were worth $137,341,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also modified their holdings of the company. Clark Wealth Partners raised its holdings in shares of Procter & Gamble by 20.6% during the 3rd quarter. Clark Wealth Partners now owns 387 shares of the company’s stock valued at $56,000 after buying an additional 66 shares during the period. KLCM Advisors Inc. lifted its position in Procter & Gamble by 0.9% during the 1st quarter. KLCM Advisors Inc. now owns 7,890 shares of the company’s stock worth $1,140,000 after acquiring an additional 70 shares in the last quarter. Midwest Professional Planners LTD. boosted its holdings in Procter & Gamble by 2.6% in the 2nd quarter. Midwest Professional Planners LTD. now owns 2,799 shares of the company’s stock worth $410,000 after acquiring an additional 70 shares during the period. Legacy Solutions LLC boosted its holdings in Procter & Gamble by 3.8% in the 2nd quarter. Legacy Solutions LLC now owns 1,928 shares of the company’s stock worth $283,000 after acquiring an additional 71 shares during the period. Finally, Yarger Wealth Strategies LLC boosted its holdings in Procter & Gamble by 1.7% in the 2nd quarter. Yarger Wealth Strategies LLC now owns 4,142 shares of the company’s stock worth $609,000 after acquiring an additional 71 shares during the period. 65.77% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of research firms have recently issued reports on PG. TD Cowen reiterated a “hold” rating and set a $150.00 price objective on shares of Procter & Gamble in a research note on Wednesday, September 30th. Barclays upped their target price on shares of Procter & Gamble from $146.00 to $152.00 and gave the company an “equal weight” rating in a research note on Tuesday, July 21st. Argus lowered shares of Procter & Gamble from a “buy” rating to a “hold” rating in a report on Friday, August 7th. Bank of America cut their price objective on shares of Procter & Gamble from $170.00 to $166.00 and set a “buy” rating on the stock in a report on Friday, July 10th. Finally, Citigroup upped their price objective on shares of Procter & Gamble from $170.00 to $180.00 and gave the company a “buy” rating in a research report on Friday, October 9th. Fourteen research analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company. According to MarketBeat, Procter & Gamble has a consensus rating of “Moderate Buy” and an average target price of $162.20.

Procter & Gamble Price Performance

PG opened at $156.97 on Thursday. The company has a market capitalization of $364.58 billion, a P/E ratio of 23.71, a PEG ratio of 3.96 and a beta of 0.39. The company has a 50-day moving average of $147.65 and a 200-day moving average of $146.83. The company has a debt-to-equity ratio of 0.43, a quick ratio of 0.47 and a current ratio of 0.68. Procter & Gamble Company has a 1-year low of $137.62 and a 1-year high of $167.25.

Procter & Gamble (NYSE:PG) last issued its quarterly earnings results on Wednesday, July 29th. The company reported $1.43 EPS for the quarter, topping the consensus estimate of $1.41 by $0.02. Procter & Gamble had a net margin of 18.44% and a return on equity of 31.36%. The business had revenue of $21.20 billion for the quarter, compared to analysts’ expectations of $21.38 billion. During the same quarter last year, the company posted $1.48 earnings per share. The company’s quarterly revenue was up 1.5% compared to the same quarter last year. Procter & Gamble has set its FY 2027 guidance at 6.890-7.110 EPS. Equities analysts expect that Procter & Gamble Company will post 6.98 EPS for the current fiscal year.

Procter & Gamble Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, November 16th. Stockholders of record on Friday, October 23rd will be given a dividend of $1.0885 per share. This represents a $4.35 dividend on an annualized basis and a dividend yield of 2.8%. The ex-dividend date is Friday, October 23rd. Procter & Gamble’s dividend payout ratio is presently 65.71%.

Insider Buying and Selling at Procter & Gamble

In related news, CEO Paul Gama sold 2,225 shares of the firm’s stock in a transaction that occurred on Monday, October 5th. The stock was sold at an average price of $145.34, for a total value of $323,381.50. Following the sale, the chief executive officer owned 51,124 shares of the company’s stock, valued at approximately $7,430,362.16. This trade represents a 4.17% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Andre Schulten sold 3,914 shares of the business’s stock in a transaction that occurred on Monday, October 5th. The shares were sold at an average price of $145.34, for a total value of $568,860.76. Following the transaction, the chief financial officer owned 65,618 shares of the company’s stock, valued at $9,536,920.12. This represents a 5.63% decrease in their position. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last three months, insiders sold 15,135 shares of company stock worth $2,189,970. Corporate insiders own 0.23% of the company’s stock.

Procter & Gamble News Summary

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: Procter & Gamble’s dividend remains a key support for the stock. The company recently recorded its 70th consecutive annual dividend increase, reinforcing its appeal to income-focused investors, particularly while interest rates remain elevated. The Ultimate Dividend Growth Stock to Buy With $100 Right Now
• Positive Sentiment: Royal Bank of Canada reaffirmed its “outperform” rating and maintained a $166 price target, implying additional upside from the referenced trading level. Benzinga analyst-rating report
• Neutral Sentiment: Investors are comparing PG’s dependable profitability and cash flow from essential household products with higher-risk consumer brands such as Nike. This supports PG’s defensive profile but does not provide a new earnings catalyst. Nike vs. Procter & Gamble
• Negative Sentiment: Procter & Gamble expects only 1% to 3% organic sales growth, raising concerns that the company’s large brands may be struggling to generate stronger underlying demand. Procter & Gamble Expects 1% to 3% Organic Growth
• Negative Sentiment: The earnings preview identifies a central risk: recovering product volumes could be offset by pricing headwinds, potentially limiting revenue growth and margins. Procter & Gamble Earnings Preview
• Negative Sentiment: Options-market activity indicates traders are positioned for PG shares to decline following the earnings release, reflecting elevated near-term uncertainty. Barchart Earnings Analysis

About Procter & Gamble

Procter & Gamble Company (NYSE: PG) is a global consumer products company that develops, manufactures and markets branded products used in households and personal care. Its portfolio includes personal health and grooming products, beauty and skin care items, baby, feminine and family care products, fabric and home care products, and oral care products.

The company’s well-known brands include Pampers, Tide, Gillette, Crest, Oral-B, Head & Shoulders, Pantene, Olay, Old Spice, Dawn, Febreze and Mr.